NORTHAMPTON, MA — When Gloucester Marine Genomics Institute (GMGI) was founded in 2013, it already had an Illumina connection-it was created with help from Illumina co-founder David Walt. Now Illumina provides in-kind donations to support its mission. Gloucester is one of several communities on Cape Ann, Massachusetts, north of Boston. The region had a thriving fishing industry for hundreds […]

Addition of next generation sequencing research panels, bioinformatics, positions IDT to become a leading oncology research solutions provider Coralville, IA — Integrated DNA Technologies, Inc. (IDT) today announced it closed on the purchase of Next Generation Sequencing (NGS) research assays from Invitae Corporation (NYSE: NVTA) under the trademarked name Archer®. The integration of IDT’s portfolio […]

— Invitae will continue to invest in its precision oncology focused lab developed test (LDT) offerings — — The transaction contributes to Invitae’s cash runway and includes a strategic supply partnership to support the growth of Invitae Personalized Cancer Monitoring™ (PCM) services — SAN FRANCISCO — Invitae (NYSE: NVTA), a leading medical genetics company, today announced […]

VIENNA — Ribbon Biolabs, the DNA synthesis company, today announced the successful implementation of their innovative InfiniSynthTM platform for the automated assembly of sequence-agnostic and long DNA. Ribbon Biolabs achieved this milestone in collaboration with HighRes® Biosolutions, a leading laboratory automation technology company. The InfiniSynthTM platform enables Ribbon Biolabs to enter the market in 2023 with a highly […]

Hadfield, UK – UK genomics company, RevoluGen Ltd. is pleased to announce it has entered into a non-exclusive distribution agreement with BioEntist of Thailand for the distribution of its Fire Monkey™ High Molecular Weight (HMW)-DNA extraction product range. Under the terms of the agreement, RevoluGen has granted BioEntist the rights to promote, market and sell […]

SAN DIEGO — Scale Biosciences, Inc. (ScaleBio), a pioneer in single-cell sequencing and combinatorial indexing technologies, has transitioned from research and development to commercial stage with the release of its first generation single-cell transcriptomics scRNAseq profiling and analysis solution, establishing new standards for accessible, scalable, and low-cost single-cell sequencing. ScaleBio’s scRNAseq solution, built upon the […]

BILLERICA, Mass. —  SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL), a technology company providing life sciences instrumentation and research services, today announced that Brian Paras has joined the company as Chief Business Officer. “Brian brings 30-plus years of product introduction & commercialization, global sales & marketing leadership, and key industry partnership & strategic alliance building to the […]

Michael Chambers, the founding CEO of Aldevron, has been elected to the board of directors for the Whitehead Institute at the Massachusetts Institute of Technology. The Whitehead Institute is a nonprofit biomedical research center in Cambridge, Massachusetts. Chambers is one of two new members elected to a six-year term on the board that were announced […]

SFW Capital-Backed Pion’s Acquisition of Two Square Science Adds Sample Preparation and Remote Monitoring Technology to Augment Its Product Portfolio Billerica, MA:  Pion, Inc. (“Pion”), a leading provider of innovative analytical solutions for drug development, has acquired Two Square Science, a company specializing in sample preparation, content uniformity and remote monitoring solutions for the life […]

Began global shipments of Xenium Analyzer, the highest throughput instrument for subcellular In Situ profiling PLEASANTON, Calif. — 10x Genomics, Inc.(Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the first commercial shipments of its Xenium platform for in situ analysis. Xenium is the next generation of targeted spatial profiling […]